PL4136091T3 - Postacie i kompozycje inhibitorów kalikreiny osoczowej - Google Patents

Postacie i kompozycje inhibitorów kalikreiny osoczowej

Info

Publication number
PL4136091T3
PL4136091T3 PL21724430.0T PL21724430T PL4136091T3 PL 4136091 T3 PL4136091 T3 PL 4136091T3 PL 21724430 T PL21724430 T PL 21724430T PL 4136091 T3 PL4136091 T3 PL 4136091T3
Authority
PL
Poland
Prior art keywords
compositions
forms
plasma kallikrein
kallikrein inhibitors
inhibitors
Prior art date
Application number
PL21724430.0T
Other languages
English (en)
Polish (pl)
Inventor
Suresh Kumar TIPPARAJU
Jeffrey Scott DEPUE
Helge Alfred Reisch
Samuel Alexander STRATFORD
Joseph Stephen HARRIS
Sarah Jocelyn FINK
Nikolaos PAPAIOANNOU
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of PL4136091T3 publication Critical patent/PL4136091T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/06—Oxalic acid
    • C07C55/07—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL21724430.0T 2020-04-17 2021-04-16 Postacie i kompozycje inhibitorów kalikreiny osoczowej PL4136091T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063011776P 2020-04-17 2020-04-17
PCT/US2021/027620 WO2021211930A1 (en) 2020-04-17 2021-04-16 Forms and compositions of inhibitors of plasma kallikrein

Publications (1)

Publication Number Publication Date
PL4136091T3 true PL4136091T3 (pl) 2025-08-18

Family

ID=75870731

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21724430.0T PL4136091T3 (pl) 2020-04-17 2021-04-16 Postacie i kompozycje inhibitorów kalikreiny osoczowej

Country Status (9)

Country Link
US (1) US20230167132A1 (https=)
EP (2) EP4623913A3 (https=)
JP (2) JP2023522331A (https=)
DK (1) DK4136091T3 (https=)
ES (1) ES3035604T3 (https=)
FI (1) FI4136091T3 (https=)
PL (1) PL4136091T3 (https=)
PT (1) PT4136091T (https=)
WO (1) WO2021211930A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019028362A1 (en) * 2017-08-04 2019-02-07 Dyax Corp. INHIBITORS OF PLASMATIC KALLIKREIN AND USES THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
EP1596869B1 (en) * 2003-01-21 2014-06-04 New Form Pharmaceuticals Inc. Novel cocrystallization
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN110015955A (zh) * 2010-07-23 2019-07-16 格吕伦塔尔有限公司 3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的盐或共晶体
WO2012097333A2 (en) * 2011-01-14 2012-07-19 Redwood Bioscience, Inc. Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
EP3765459A1 (en) 2018-03-13 2021-01-20 Shire Human Genetic Therapies, Inc. Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof

Also Published As

Publication number Publication date
ES3035604T3 (en) 2025-09-05
WO2021211930A1 (en) 2021-10-21
EP4136091A1 (en) 2023-02-22
EP4136091B1 (en) 2025-05-28
FI4136091T3 (fi) 2025-07-25
EP4623913A2 (en) 2025-10-01
US20230167132A1 (en) 2023-06-01
WO2021211930A8 (en) 2021-12-16
JP2023522331A (ja) 2023-05-30
JP2025142238A (ja) 2025-09-30
PT4136091T (pt) 2025-08-22
EP4623913A3 (en) 2025-12-24
DK4136091T3 (da) 2025-08-18

Similar Documents

Publication Publication Date Title
IL289534A (en) Parp1 inhibitors
DK4031547T3 (da) Plasmakallikreininhibitorer og anvendelser deraf
EP4165033A4 (en) SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF
PL4355749T3 (pl) Trójpierścieniowe inhibitory parp1 i ich zastosowania
EP4422623A4 (en) PROLYL HYDROXYLASE (PHD) DOMAIN-CONTAINING PROTEIN INHIBITORS AND THEIR USES
IL320739A (en) rock2 inhibitors
IL299840A (en) Inhibitors of complement factors and uses thereof
IL321357A (en) KIF18A inhibitors and their uses
EP4333821A4 (en) SARS-COV-2 INHIBITORS
IL299700A (en) Kcnt1 inhibitors and methods of use
EP4499104A4 (en) TYK2 INHIBITORS AND THEIR USES
IL316616A (en) ROCK2 inhibitors
EP4225310A4 (en) HETEROARYL AMIDE INHIBITORS OF CD38
IL314330A (en) Apol1 inhibitors and methods of use
IL309571A (en) Cdk2 inhibitors and methods of using the same
DK4288036T3 (da) Formuleringer af en plasmakallikreinhæmmer
IL281451A (en) Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
EP4244205A4 (en) IRE1ALPHA INHIBITORS AND THEIR USES
EP4161917A4 (en) GRK2 INHIBITORS AND THEIR USES
PL4136091T3 (pl) Postacie i kompozycje inhibitorów kalikreiny osoczowej
IL281450A (en) Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor
EP4387963C0 (en) PHENYL AND PYRIDOPYRAZOLE DERIVATIVES AS DDR1 INHIBITORS
EP4408853A4 (en) LPXC INHIBITORS AND THEIR USES
EP4384164A4 (en) HYPOXIA-INDUCIBLE FACTOR INHIBITORS
DK4192813T3 (da) Inhibitorer af transglutaminaser